A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)Jennifer J. Knox, Lesley Seymour, Timothy W. Synold et al.|Investigational New Drugs|2008Cited by 67